Q1 2024 Holdings
Filed 2024-05-15 | 70 holdings | $3.1B | 13F-HR | View on SEC ↗ · Holdings Table ↗
Sign in to see sub-manager breakdown
| Issuer | Class | CUSIP | Value ↓ | Shares | % Portfolio |
|---|---|---|---|---|---|
| Guardant Health Inc | NOTE11/1 | 40131MAB5 | $183.6M | $268,252,000 | 5.9% |
| Bridgebio Pharma Inc | NOTE 2.500% 3/1 | 10806XAB8 | $146.2M | $135,838,000 | 4.7% |
| Exact Sciences Corp | NOTE 0.375% 3/0 | 30063PAC9 | $133.1M | $144,000,000 | 4.3% |
| Novocure LTD | NOTE11/0 | 67011XAB9 | $124.6M | $135,834,000 | 4.0% |
| Apogee Therapeutics Inc(APGE) | COM | 03770N101 | $122.4M | 1,842,515 | 3.9% |
| Nuvasive Inc | NOTE 0.375% 3/1 | 670704AJ4 | $109.0M | $114,206,000 | 3.5% |
| Neurocrine Biosciences Inc(NBIX) | COM | 64125C109 | $100.7M | 730,209 | 3.2% |
| Argenx SE(ARGX) | SPONSORED ADR | 04016X101 | $86.5M | 219,824 | 2.8% |
| Vaxcyte Inc(PCVX) | COM | 92243G108 | $82.8M | 1,212,703 | 2.7% |
| Neogenomics Inc | NOTE 0.250% 1/1 | 64049MAB6 | $82.6M | $103,580,000 | 2.7% |
| Dexcom Inc | NOTE 0.250%11/1 | 252131AK3 | $71.6M | $65,000,000 | 2.3% |
| Legend Biotech Corp(LEGN) | SPONSORED ADS | 52490G102 | $69.8M | 1,243,795 | 2.2% |
| Insmed Inc | NOTE 1.750% 1/1 | 457669AA7 | $69.4M | $64,887,000 | 2.2% |
| Insulet Corp | NOTE 0.375% 9/0 | 45784PAK7 | $68.9M | $66,000,000 | 2.2% |
| Penumbra Inc(PEN) | COM | 70975L107 | $66.0M | 295,892 | 2.1% |
| Maravai Lifesciences Hldgs I(MRVI) | COM CL A | 56600D107 | $62.6M | 7,221,960 | 2.0% |
| Sarepta Therapeutics Inc | NOTE 1.250% 9/1 | 803607AD2 | $59.3M | $50,666,000 | 1.9% |
| Viking Therapeutics Inc(VKTX) | COM | 92686J106 | $58.5M | 713,100 | 1.9% |
| Xenon Pharmaceuticals Inc(XENE) | COM | 98420N105 | $56.3M | 1,308,011 | 1.8% |
| Irhythm Technologies Inc(IRTC) | COM | 450056106 | $56.1M | 483,257 | 1.8% |
| Align Technology Inc(ALGN) | COM | 016255101 | $55.5M | 169,252 | 1.8% |
| Bridgebio Pharma Inc | NOTE 2.250% 2/0 | 10806XAD4 | $55.1M | $67,294,000 | 1.8% |
| Ironwood Pharmaceuticals Inc | NOTE 1.500% 6/1 | 46333XAH1 | $53.7M | $52,740,000 | 1.7% |
| Guardant Health Inc(GH) | COM | 40131M109 | $51.1M | 2,476,804 | 1.6% |
| Travere Therapeutics Inc | NOTE 2.500% 9/1 | 761299AB2 | $49.6M | $56,031,000 | 1.6% |
| CG Oncology Inc(CGON) | COM | 156944100 | $49.6M | 1,130,235 | 1.6% |
| Keros Therapeutics Inc(KROS) | COM | 492327101 | $48.8M | 737,379 | 1.6% |
| Transmedics Group Inc(TMDX) | COM | 89377M109 | $45.4M | 614,531 | 1.5% |
| Avadel Pharmaceuticals PLC | SPONSORED ADR | 05337M104 | $45.1M | 2,668,549 | 1.5% |
| Glaukos Corp(GKOS) | COM | 377322102 | $42.5M | 450,676 | 1.4% |
| Paragon 28 Inc(FNAUSD) | COM | 69913P105 | $41.6M | 3,365,609 | 1.3% |
| Intuitive Surgical Inc(ISRG) | COM NEW | 46120E602 | $40.1M | 100,500 | 1.3% |
| DAY One Biopharmaceuticals I(DAWN) | COM | 23954D109 | $35.9M | 2,173,704 | 1.2% |
| Karyopharm Therapeutics Inc | NOTE 3.000%10/1 | 48576UAA4 | $35.8M | $65,976,000 | 1.2% |
| Alphatec Hldgs Inc | NOTE 0.750% 8/0 | 02081GAB8 | $33.9M | $32,434,000 | 1.1% |
| 4D Molecular Therapeutics in(FDMT) | COM | 35104E100 | $33.5M | 1,052,485 | 1.1% |
| Orthopediatrics Corp(KIDS) | COM | 68752L100 | $32.3M | 1,107,770 | 1.0% |
| Krystal Biotech Inc(KRYS) | COM | 501147102 | $31.5M | 177,089 | 1.0% |
| Relay Therapeutics Inc(RLAY) | COM | 75943R102 | $31.1M | 3,743,999 | 1.0% |
| Ironwood Pharmaceuticals Inc(IRWD) | COM CL A | 46333X108 | $30.4M | 3,489,843 | 1.0% |
| Kiniksa Pharmaceuticals LTD | COM CL A | G5269C101 | $27.5M | 1,392,716 | 0.9% |
| Thermo Fisher Scientific Inc(TMO) | COM | 883556102 | $27.4M | 47,149 | 0.9% |
| Repligen Corp(RGEN) | COM | 759916109 | $26.3M | 142,836 | 0.8% |
| Nevro Corp(NVROEUR) | COM | 64157F103 | $25.7M | 1,776,368 | 0.8% |
| Inspire MED SYS Inc(INSP) | COM | 457730109 | $21.8M | 101,492 | 0.7% |
| Cullinan Oncology Inc(CGEM) | COM | 230031106 | $21.1M | 1,240,865 | 0.7% |
| Tourmaline BIO Inc(TRML) | COM | 89157D105 | $20.8M | 906,820 | 0.7% |
| Lexeo Therapeutics Inc(LXEO) | COM | 52886X107 | $20.7M | 1,322,277 | 0.7% |
| Ironwood Pharmaceuticals Inc | NOTE 0.750% 6/1 | 46333XAF5 | $19.9M | $20,000,000 | 0.6% |
| Haemonetics Corp Mass | NOTE3/0 | 405024AB6 | $19.8M | $21,500,000 | 0.6% |